全球过敏诊断市场规模、份额、趋势和成长分析报告（2026-2034年）

预计过敏诊断市场将从 2025 年的 64.1 亿美元成长到 2034 年的 171.9 亿美元，2026 年至 2034 年的复合年增长率为 11.58%。

随着全球过敏性疾病的增加，全球过敏诊断市场正稳定成长。都市化和日益严重的环境污染加剧了过敏症的发生率。人们对诊断检测的认识不断提高，以及检测管道的改善，显着推动了市场扩张，而医疗基础设施的扩张也进一步增强了市场需求。

关键成长要素包括体外诊断技术和就地检验解决方案的进步。早期检测有助于制定更有效的治疗方案和管理。儿童和老年人口的成长也促使检测需求增加。此外，医疗保健支出的增加也推动了开发中国家对检测技术的采用。

随着个人化医疗的日益普及，市场前景依然光明。多重检测平台的发展将提高效率和准确性。加大对过敏预防的宣传力道也将提升诊断率。在医疗技术进步的推动下，市场预计将持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球过敏诊断市场：按类型划分

• 市场分析、洞察与预测
• 消耗品
• 装置
• 服务

第五章 全球过敏诊断市场：依检测类型划分

• 市场分析、洞察与预测
• 体内试验
• 体外检查

第六章 全球过敏诊断市场：依过敏原分类

• 市场分析、洞察与预测
• 吸入性过敏原
• 食物过敏原
• 药物过敏原
• 其他过敏原

第七章 全球过敏诊断市场：依最终用户划分

• 市场分析、洞察与预测
• 医院检查室和诊所
• 诊断检查室
• 学术研究机构

第八章 全球过敏诊断市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 亚太其他地区
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific Inc
  • Siemens Healthineers AG
  • Danaher
  • Canon Inc
  • Minaris Medical America Inc
  • Eurofins Scientific
  • Euroimmun Medizinische Labordiagnostika Ag
  • BioMAfA（C）Rieux SA
  • Stallergenes Greer Ltd
  • HollisterStier Allergy
  • Omega Diagnostics Group PLC

The Allergy Diagnostics Market size is expected to reach USD 17.19 Billion in 2034 from USD 6.41 Billion (2025) growing at a CAGR of 11.58% during 2026-2034.

The Global Allergy Diagnostics market has witnessed steady growth due to rising prevalence of allergic conditions worldwide. Increasing urbanization and environmental pollution have contributed to higher allergy incidence. Improved awareness and access to diagnostic testing have significantly supported market expansion. Growing healthcare infrastructure further strengthens demand.

Key growth drivers include advancements in in vitro diagnostic technologies and point-of-care testing solutions. Early detection enables effective treatment planning and management. Rising pediatric and geriatric populations also contribute to increased testing demand. Additionally, expanding healthcare expenditure supports adoption in developing economies.

Future prospects remain promising as personalized medicine gains traction. Development of multiplex testing platforms will enhance efficiency and accuracy. Growing awareness campaigns about allergy prevention will boost diagnostic rates. The market is expected to experience consistent growth driven by healthcare advancements.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Consumables
• Instruments
• Services

By Test Type

• In Vivo Tests
• In Vitro Tests

By Allergen

• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

By End User

• Hospitals-Based Laboratories & Clinics
• Diagnostic Laboratories
• Academic Research Institutes

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Siemens Healthineers AG, Danaher, Canon Inc, Minaris Medical America Inc, Eurofins Scientific, Euroimmun Medizinische Labordiagnostika Ag, bioMrieux SA, Stallergenes Greer Ltd, HollisterStier Allergy, Omega Diagnostics Group PLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. In Vivo Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. In Vitro Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY ALLERGEN 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Allergen
• 6.2. Inhaled Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Food Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Drug Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals-Based Laboratories & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Test Type
  • 8.2.3 By Allergen
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Test Type
  • 8.3.3 By Allergen
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Test Type
  • 8.4.3 By Allergen
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Test Type
  • 8.5.3 By Allergen
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Test Type
  • 8.6.3 By Allergen
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ALLERGY DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Siemens Healthineers AG
  • 10.2.3 Danaher
  • 10.2.4 Canon Inc
  • 10.2.5 Minaris Medical America Inc
  • 10.2.6 Eurofins Scientific
  • 10.2.7 Euroimmun Medizinische Labordiagnostika Ag
  • 10.2.8 BioMAfA(C)Rieux SA
  • 10.2.9 Stallergenes Greer Ltd
  • 10.2.10 HollisterStier Allergy
  • 10.2.11 Omega Diagnostics Group PLC